Nice to see you again. As usual, we are hustling the short people off to their various schools and feeding the mascot. Nonetheless, there is always time to view something interesting. And so, as we reach for our daily ammunition - which we call coffee - please join us in perusing some of the latest developments. Hope your days goes well...
Roche Sales Fall On Lower Tamiflu Demand (Bloomberg News)
HIV Drug Sales Boost Gilead Profits (TheStreet.com)
Glaxo's Tykerb Reduces Breast Cancer Stem Cells (Yahoo/Reuters)
Pfizer May Face Class Action Lawsuit Over Neurontin (Bloomberg News)
Lipitor Didn't Boost Aricept Efficacy (MarketWatch)
Pfizer, Avant Sign $50M Cancer Deal (Boston Business Journal)